Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Amlophar Capsules (5 mg amlodipine) Produced by Julphar / UAE versus Amlor® Capsules (5 mg amlodipine) Produced by Pfizer / KSA, in healthy subjects under fasting condition. | SFDA | Ongoing | Amlophar | BE | Dec-17 | Saudi Ajal |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glymide tablets (5 mg glibenclamide) Produced by Julphar / UAE versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition. | SFDA | Ongoing | Glymide | BE | 13-2017 | Saudi Ajal |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Narapril tablets (20 mg enalapril) Produced by Julphar / UAE versus Renitec® tablets (20 mg enalapril) Produced by Merck Sharp & Dohme / UK, in healthy subjects under fasting condition. | SFDA | Ongoing | Narapril | BE | 14-2017 | Saudi Ajal |
| Randomized, three-way, three-period, single oral dose, open-label, crossover, bioequivalence study to compare Torvacol tablets (20 mg atorvastatin) Produced by JPM / Jordan, versus Lipitor® tablets (20 mg atorvastatin) Produced by Pfizer / Irland in healthy subjects under fasting conditions. | SFDA | Ongoing | Torvacol | BE | 15-2017 | Saudi Ajal |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Amlodar Capsules (10 mg amlodipine) Produced by Dar AlDawa / Jordan versus Amlor® Capsules (10 mg amlodipine) Produced by Pfizer / KSA, in healthy subjects under fasting condition. | SFDA | Ongoing | Amlodar | BE | 16-2017 | Saudi Ajal |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glibil tablets (5 mg glibenclamide) Produced by Hikma / Jordan versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition. | SFDA | Ongoing | Glibil | BE | 17-2017 | Saudi Ajal |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Diatab tablets (5 mg glibenclamide) Produced by SPIMACO / KSA versus Daonil® tablets (5 mg glibenclamide) Produced by Sanofi- Aventis / Germany, in healthy subjects under fed condition. | SFDA | Ongoing | Diatab | BE | 18-2017 | Saudi Ajal |
| "DIREGL07563 RATIONAL studyAn obseRvationAl registry To assess urInary albumin evOlution in Saudi hyperteNsive patients with the current treatment local ALgorithm " | SANOFI | Ongoing | APROVEL / Irbesartan | 4 | 3 | King Abdulaziz University Hospital (Jeddah) |
| Grazoprevir/Elbasvir For Treatment Of Hepatitis C Virus Genotype 4 Post Kidney Transplant | King Faisal Specialist Hospital & Research Center (MSD grant) | Ongoing | Zepatier | 4 | 2171009 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Solifenacin succinate film-coated tablets (10 mg solifenacin succinate) versus Vesicare® film-coated tablets (10 mg solifenacin succinate), in healthy subjects under fasting condition. | SPIMACO ADDWAEIH | Ongoing | solifenacin succinate | BE | Feb-17 | Saudi Ajal |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.